Neurodegenerative diseases and oxidative stress

被引:2995
作者
Barnham, KJ
Masters, CL
Bush, AI [1 ]
机构
[1] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[2] Mental Hlth Res Inst Victoria, Parkville, Vic 3010, Australia
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Dept Psychiat, Charlestown, MA 02129 USA
[4] Harvard Univ, Sch Med, Lab Oxidat Biol Genet & Aging Res Unit, Charlestown, MA 02129 USA
关键词
D O I
10.1038/nrd1330
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Oxygen is vital for life but is also potentially dangerous, and a complex system of checks and balances exists for utilizing this essential element. Oxidative stress is the result of an imbalance in pro-oxidant/antioxidant homeostasis that leads to the generation of toxic reactive oxygen species. The systems in place to cope with the biochemistry of oxygen are complex, and many questions about the mechanisms of oxygen regulation remain unanswered. However, this same complexity provides a number of therapeutic targets, and different strategies, including novel metal - protein attenuating compounds, aimed at a variety of targets have shown promise in clinical studies.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 139 条
[51]   Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease [J].
Gibson, GE .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (11) :1061-1070
[52]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[53]   Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis [J].
Goto, JJ ;
Zhu, HN ;
Sanchez, RJ ;
Nersissian, A ;
Gralla, EB ;
Valentine, JS ;
Cabelli, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :1007-1014
[54]  
Grundman M, 2000, AM J CLIN NUTR, V71, p630S
[55]   MOTOR-NEURON DEGENERATION IN MICE THAT EXPRESS A HUMAN CU,ZN SUPEROXIDE-DISMUTASE MUTATION [J].
GURNEY, ME ;
PU, HF ;
CHIU, AY ;
DALCANTO, MC ;
POLCHOW, CY ;
ALEXANDER, DD ;
CALIENDO, J ;
HENTATI, A ;
KWON, YW ;
DENG, HX ;
CHEN, WJ ;
ZHAI, P ;
SUFIT, RL ;
SIDDIQUE, T .
SCIENCE, 1994, 264 (5166) :1772-1775
[56]   Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability [J].
Habgood, MD ;
Liu, ZD ;
Dehkordi, LS ;
Khodr, HH ;
Abbott, J ;
Hider, RC .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (11) :1305-1310
[57]  
Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
[58]   Amyloid, the presenilins and Alzheimer's disease [J].
Hardy, J .
TRENDS IN NEUROSCIENCES, 1997, 20 (04) :154-159
[59]   Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia [J].
Hausse, AO ;
Aggoun, Y ;
Bonnet, D ;
Sidi, D ;
Munnich, A ;
Rötig, A ;
Rustin, P .
HEART, 2002, 87 (04) :346-349
[60]   Oxidation of aβ and plaque biogenesis in Alzheimer's disease and Down syndrome [J].
Head, E ;
Garzon-Rodriguez, W ;
Johnson, JK ;
Lott, IT ;
Cotman, CW ;
Glabe, C .
NEUROBIOLOGY OF DISEASE, 2001, 8 (05) :792-806